Literature DB >> 23494280

[Nodular lymphocyte-predominant Hodgkin's lymphoma and differential diagnoses].

S Hartmann1, S Cogliatti, M-L Hansmann.   

Abstract

Nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL) is a rare subtype of Hodgkin's lymphoma. The histological patterns of NLPHL variants are characterized by different localizations of the tumor cells, intranodular and perinodular and by the varying composition of the microenvironment. T-cell/histiocyte-rich B-cell lymphoma may be the result of an aggressive transformation of NLPHL. Classical lymphocyte-rich Hodgkin's lymphoma can usually be clearly distinguished from NLPHL by the immunophenotype of the tumor cells. Further differential diagnoses include follicular lymphoma and the follicular variant of peripheral T-cell lymphoma. Angioimmunoblastic T-cell lymphoma with CD20-positive blasts represents a differential diagnosis to the diffuse variants of NLPHL.

Entities:  

Mesh:

Year:  2013        PMID: 23494280     DOI: 10.1007/s00292-013-1747-4

Source DB:  PubMed          Journal:  Pathologe        ISSN: 0172-8113            Impact factor:   1.011


  56 in total

Review 1.  Angioimmunoblastic T-cell lymphoma.

Authors:  Ahmet Dogan; Ayoma D Attygalle; Chara Kyriakou
Journal:  Br J Haematol       Date:  2003-06       Impact factor: 6.998

2.  Peripheral T-cell lymphoma with distinct perifollicular growth pattern: a distinct subtype of T-cell lymphoma?

Authors:  T Rüdiger; R Ichinohasama; M M Ott; S Müller-Deubert; I Miura; G Ott; H K Müller-Hermelink
Journal:  Am J Surg Pathol       Date:  2000-01       Impact factor: 6.394

3.  Molecular cytogenetic analyses of immunoglobulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition.

Authors:  Christoph Renné; José Ignacio Martín-Subero; Martin-Leo Hansmann; Reiner Siebert
Journal:  J Mol Diagn       Date:  2005-08       Impact factor: 5.568

4.  Lymphocyte-predominant Hodgkin's disease. An immunohistochemical analysis of 208 reviewed Hodgkin's disease cases from the German Hodgkin Study Group.

Authors:  R von Wasielewski; M Werner; R Fischer; M L Hansmann; K Hübner; D Hasenclever; J Franklin; M Sextro; V Diehl; A Georgii
Journal:  Am J Pathol       Date:  1997-03       Impact factor: 4.307

Review 5.  Advances in the treatment of Hodgkin lymphoma.

Authors:  Dennis A Eichenauer; Andreas Engert
Journal:  Int J Hematol       Date:  2012-10-11       Impact factor: 2.490

6.  Cytogenetic findings in nodular paragranuloma (Hodgkin's disease with lymphocytic predominance; nodular) and in progressively transformed germinal centers.

Authors:  M L Hansmann; E Gödde-Salz; P K Hui; H K Müller-Hermelink; K Lennert
Journal:  Cancer Genet Cytogenet       Date:  1986-04-15

7.  Progressive transformation of germinal centers with and without association to Hodgkin's disease.

Authors:  M L Hansmann; C Fellbaum; P K Hui; P Moubayed
Journal:  Am J Clin Pathol       Date:  1990-02       Impact factor: 2.493

8.  Diffuse lymphocyte-predominant Hodgkin's disease (diffuse paragranuloma). A variant of the B-cell-derived nodular type.

Authors:  M L Hansmann; H Stein; F Dallenbach; C Fellbaum
Journal:  Am J Pathol       Date:  1991-01       Impact factor: 4.307

9.  Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG).

Authors:  Holger Schulz; Ute Rehwald; Franck Morschhauser; Thomas Elter; Christoph Driessen; Thomas Rüdiger; Peter Borchmann; Roland Schnell; Volker Diehl; Andreas Engert; Marcel Reiser
Journal:  Blood       Date:  2007-10-15       Impact factor: 22.113

10.  Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis.

Authors:  Verena Brune; Enrico Tiacci; Ines Pfeil; Claudia Döring; Susan Eckerle; Carel J M van Noesel; Wolfram Klapper; Brunangelo Falini; Anja von Heydebreck; Dirk Metzler; Andreas Bräuninger; Martin-Leo Hansmann; Ralf Küppers
Journal:  J Exp Med       Date:  2008-09-15       Impact factor: 14.307

View more
  1 in total

Review 1.  [Malignant lymphomas in children and adolescents. Practical knowledge for diagnosis].

Authors:  I Oschlies; W Klapper
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.